Literature DB >> 14713848

Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma.

Masamichi Yamauchi1, Hiroaki Kataoka, Hiroshi Itoh, Tomoko Seguchi, Yoshiniro Hasui, Yukio Osada.   

Abstract

PURPOSE: Hepatocyte growth factor (HGF) and its receptor MET have been implicated in kidney development and renal cell carcinoma (RCC) progression. HGF is secreted as an inactive proform and it must be activated to initiate MET signaling. HGF activator (HGFA) activates pro-HGF in injured tissue. We evaluated the expression of HGFA and its endogenous inhibitors HAI-1 and HAI-2 in normal kidney and RCC.
MATERIALS AND METHODS: We examined the gene expression of HGFA, HAI-1, HAI-2, HGF and MET in a normal kidney by laser captured microdissection, followed by reverse transcriptase-polymerase chain reaction. We also quantified the mRNA levels of these proteins in 14 RCC cases by real-time reverse transcriptase-polymerase chain reaction.
RESULTS: HAI-1 and HAI-2 were abundant in the normal kidney. The uriniferous tubules showed the highest levels of HAI-1 and HAI-2 mRNA. HGFA was hardly detectable in the normal kidney. However, in the kidney with RCC a low but distinct level of HGFA mRNA became detectable in the tumor and adjacent renal tissue. The HAI-1 mRNA level was significantly and consistently down-regulated in RCC relative to normal tissue. HAI-2 mRNA was also significantly low in the advanced stage of RCC. MET was up-regulated in most cases of RCC.
CONCLUSIONS: HAI-1 and HAI-2 were expressed in renal tubular epithelial cells. The expression of the 2 HAIs was significantly down-regulated in RCC, whereas HGFA expression was enhanced in the diseased kidney, suggesting an imbalance between HAI and its target proteinases, including HGFA, in favor of proteinase activities in RCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14713848     DOI: 10.1097/01.ju.0000092861.21122.d2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.

Authors:  Roman Szabo; John P Hobson; Karin List; Alfredo Molinolo; Chen-Yong Lin; Thomas H Bugge
Journal:  J Biol Chem       Date:  2008-08-19       Impact factor: 5.157

2.  Transcriptome analysis of human gastric cancer.

Authors:  Jung-Hwa Oh; Jin Ok Yang; Yoonsoo Hahn; Mi-Rang Kim; Sang-Soon Byun; Yeo-Jin Jeon; Jeong-Min Kim; Kyu-Sang Song; Seung-Moo Noh; Sangsoo Kim; Hyang-Sook Yoo; Yong Sung Kim; Nam-Soon Kim
Journal:  Mamm Genome       Date:  2005-12-08       Impact factor: 2.957

Review 3.  The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na(+) channel (ENaC): IUPHAR Review 19.

Authors:  Emilie Boscardin; Omar Alijevic; Edith Hummler; Simona Frateschi; Stephan Kellenberger
Journal:  Br J Pharmacol       Date:  2016-08-10       Impact factor: 8.739

4.  Hepatocyte growth factor system in the mouse uterus: variation across the estrous cycle and regulation by 17-beta-estradiol and progesterone.

Authors:  Xuan Zhang
Journal:  Biol Reprod       Date:  2010-02-10       Impact factor: 4.285

5.  Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.

Authors:  Satoru Sugie; Shoichiro Mukai; Koji Yamasaki; Toyoharu Kamibeppu; Hiromasa Tsukino; Toshiyuki Kamoto
Journal:  Hum Cell       Date:  2015-08-07       Impact factor: 4.174

Review 6.  Targeting the Met signaling pathway in renal cancer.

Authors:  Alessio Giubellino; W Marston Linehan; Donald P Bottaro
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

7.  A Grhl2-dependent gene network controls trophoblast branching morphogenesis.

Authors:  Katharina Walentin; Christian Hinze; Max Werth; Nadine Haase; Saaket Varma; Robert Morell; Annekatrin Aue; Elisabeth Pötschke; David Warburton; Andong Qiu; Jonathan Barasch; Bettina Purfürst; Christoph Dieterich; Elena Popova; Michael Bader; Ralf Dechend; Anne Cathrine Staff; Zeliha Yesim Yurtdas; Ergin Kilic; Kai M Schmidt-Ott
Journal:  Development       Date:  2015-03-15       Impact factor: 6.868

8.  Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer.

Authors:  Jingjia Ye; Haixia Cheng; Yi Wang; Jiang Cao
Journal:  Hum Cell       Date:  2013-08-27       Impact factor: 4.174

9.  Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

Authors:  Joanna Selzer-Plon; Jette Bornholdt; Stine Friis; Hanne C Bisgaard; Inger Mb Lothe; Kjell M Tveit; Elin H Kure; Ulla Vogel; Lotte K Vogel
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

10.  Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women.

Authors:  Haile F Yancy; Jacquline A Mason; Sharla Peters; Charles E Thompson; George K Littleton; Marti Jett; Agnes A Day
Journal:  J Carcinog       Date:  2007-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.